Exhibit 10.4

Revision/License Agreement dated April 15th, 2003


                           REVISION/ LICENSE AGREEMENT

THIS  Agreement  dated April 15th,  2003 is between  TerraStar  Marketing,  Inc.
("Licensor"), whose address is 74-040 Hwy 111, Suite JJ1, Palm Desert Ca, 92260,
TerraStar Data Inc. ("Data"),  same address,  and Eclipse  Entertainment  Group,
Inc., a Nevada  corporation  having a principal place of business  located 10520
Venice Boulevard, Culver City, California, 90232 ("Licensee").

                                TABLE OF CONTENTS

RECITALS
1.  EFFECTIVE DATE
2.  DEFINITIONS
3.  WARRANTY, SUPERIOR RIGHTS AND REPRESENTATIONS
4.  LICENSE
5.  PAYMENTS AND REPORTS
6.  TERM AND TERMINATION
7.  ASSIGNMENT
8.  INDEMNIFICATION
9.  USE OF LICENSOR AND COMPONENT'S NAME
10. CONFIDENTIAL INFORMATION
11. ALTERNATE DISPUTE RESOLUTION
12. GENERAL
SIGNATURES

                                    RECITALS

     A.   Licensor,  Data and  Licensee  entered  into an  Agreement  called the
          Closing/Common  Stock Purchase Agreement" dated December 31, 2002. The
          Parties wish to revise and replace that Agreement with this Agreement.

     B.   Licensor owns the  exclusive  license  rights to the Licensed  Subject
          Matter, which Licensed Subject Matter was developed by Data.

     C.   Licensor  desires to have the Licensed  Subject  Matter  developed and
          used for the benefit of Licensee.

     D.   Licensee wishes to obtain a license from Licensor.

NOW,  THEREFORE,  in  consideration  of the mutual covenants and premises herein
contained, the parties agree as follows:

1. EFFECTIVE DATE

This Agreement is effective April 15, 2003 ("Effective Date").

2. DEFINITIONS

As used in this Agreement, the following terms have the meanings indicated:
<PAGE>
2.1 "AFFILIATE"  means any business entity more than 50% owned by Licensee,  any
business  entity,  which owns more than 50% of Licensee,  or any business entity
that is more  than 50%  owned by a  business  entity  that owns more than 50% of
Licensee.

2.2.1 "EXCLUSIVE LICENSED FIELD" means the Pharmaceutical  Computer Hardware and
Software  Technology  field as related  to Data's  task  specific  hardware/Open
Source Software based computer  requiring no special  configuration  or software
installation.  The  Product  has been  designed  to  provide  computer  users in
specialty  markets  with a  versatile  and  re-configurable  alternative  to the
standardized  PC.  The  TaskStation's(TM)   constantly  upgraded  "software  and
applications   package"   includes  an  extensive  suite  of  popular   software
applications pre-loaded in an all in one PC device. The existing TaskStation(TM)
devices have now been integrated  with the supporting  Internet based portal and
demonstration services suites and are now operational. The Internet based portal
and  services  suites are  designed to be custom  configured  for each market as
determined by the requirements of the marketing  license holder and its clients.
Development  on the  TaskStation(TM)  production  prototypes in either a PC or a
laptop configuration is now completed.

2.2.2 "NON EXCLUSIVE LICENSED FIELD" means the General Medical Computer Hardware
and Software  Technology field as related to Data's task specific  hardware/Open
Source Software based computer  requiring no special  configuration  or software
installation.  The  Product  has been  designed  to  provide  computer  users in
specialty  markets  with a  versatile  and  re-configurable  alternative  to the
standardized  PC.  The  TaskStation's(TM)   constantly  upgraded  "software  and
applications   package"   includes  an  extensive  suite  of  popular   software
applications pre-loaded in an all in one PC device. The existing TaskStation(TM)
devices have now been integrated  with the supporting  Internet based portal and
demonstration services suites and are now operational. The Internet based portal
and  services  suites are  designed to be custom  configured  for each market as
determined by the requirements of the marketing  license holder and its clients.
Development  on the  TaskStation(TM)  production  prototypes in either a PC or a
laptop configuration is now completed.

2.3 "LICENSED  PRODUCT" means any product Sold by Licensee  comprising  Licensed
Subject Matter pursuant to this Agreement.

2.4  "LICENSED  SUBJECT  MATTER"  means the  exclusive  marketing  rights to the
Licensed  Product  within  the  Pharmaceutical  sector  and  the  non  exclusive
marketing rights to the Licensed Product within the medical sector.

2.5 "LICENSED TERRITORY" means the United States of America.

2.6 "NET SALES" means the gross  revenues  received by Licensee from the Sale of
Licensed  Products  less sales and/or use taxes  actually  paid,  import  and/or
export duties actually paid,  outbound  transportation  prepaid or allowed,  and
amounts  allowed or credited due to returns (not to exceed the original  billing
or invoice amount).

2.7 "SALE OR SOLD" means the transfer or disposition  of a Licensed  Product for
value to a party other than Licensee.

2.8 "TECHNOLOGY RIGHTS" means Data's rights in technical information,  know-how,
processes,  procedures,  compositions,  devices, methods,  formulas,  protocols,
techniques,  software,  designs,  drawings  or data  created by Data  before the
Effective Date.
<PAGE>
3. WARRANTY: SUPERIOR-RIGHTS

3.1 Licensor  represents and warrants its belief that (i) it is the owner of the
entire right, title, and interest in and to Licensed Subject Matter, (ii) it has
the sole  right to grant  licenses  thereunder,  and (iii) it has not  knowingly
granted  licenses  thereunder  to any other  entity that would  restrict  rights
granted to Licensee except as stated herein.

3.2 Licensee  understands  and  acknowledges  that Licensor,  by this Agreement,
makes no  representation  as to the operability or fitness for any use,  safety,
efficacy,  ability to obtain regulatory approval, and/or breadth of the Licensed
Subject Matter.

3.3 Licensee,  by execution hereof,  acknowledges,  covenants and agrees that it
has not been induced in any way by Licensor or its  employees to enter into this
Agreement,  and  further  warrants  and  represents  that  (i) it has  conducted
sufficient due diligence with respect to all items and issues pertaining to this
Article 3 and all other matters pertaining to this Agreement;  and (ii) Licensee
has adequate knowledge and expertise,  or has utilized  knowledgeable and expert
consultants,  to adequately conduct the due diligence,  and agrees to accept all
risks inherent herein.

4. LICENSE

4.1 Licensor  hereby  grants to Licensee an  exclusive  license  under  Licensed
Subject Matter to sell Licensed  Products within the Licensed  Territory for use
within the Exclusive and Non Exclusive  Licensed Field. This grant is subject to
the payment by Licensee to Licensor of all consideration as provided herein, and
is further subject to rights retained by Licensor and Data to:

     a.  Publish  the  general  scientific  findings  from  research  related to
     Licensed  Subject Matter  subject to the terms of Section 10,  Confidential
     Information; and

     b. Use  Licensed  Subject  Matter for  research,  teaching  and  developing
     additional Licensed Products and other related purposes.

4.2  Licensee  may extend the license  granted  herein to any  Affiliate  if the
Affiliate consents to be bound by this Agreement to the same extent as Licensee.

4.3 Licensee may grant sublicenses consistent with this Agreement if Licensee is
responsible for the operations of its sublicensees relevant to this Agreement as
if Licensee carried out the operations. Licensee must deliver to Licensor a true
and correct copy of each sublicense granted by Licensee, and any modification or
termination  thereof,   within  30  days  after  execution,   modification,   or
termination. When this Agreement is terminated, all existing sublicenses granted
by Licensee must be assigned to Licensor.
<PAGE>
5. PAYMENTS AND REPORTS

5.1 In  consideration  of rights  granted by  Licensor  to  Licensee  under this
Agreement, Licensee will pay Licensor the following:

     a. A non-refundable  license fee in the amount of 1,500,000 shares of Class
     A Preferred stock with six (6) to one (1) voting and conversion rights, due
     and payable when this Agreement is executed by Licensee;

6. TERM AND TERMINATION

6.1 The term of this  Agreement  is from the  Effective  Date for a period of 10
years.

6.2 This Agreement will earlier terminate:

     a.  automatically  if Licensee  becomes bankrupt or insolvent and/or if the
     business of Licensee  is placed in the hands of a  receiver,  assignee,  or
     trustee, whether by voluntary act of Licensee or otherwise; or

     b. upon 90 days  written  notice if  Licensee  breaches  or defaults on any
     other obligation under this Agreement, unless, before the end of the 30 day
     period,  Licensee has cured the default or breach and so notifies Licensor,
     stating the manner of the cure; or

     c. at any time by mutual written  agreement  between Licensee and Licensor,
     upon 180 days written notice to all parties and subject to any terms herein
     which survive termination.

6.3 If this Agreement is terminated for any cause:

     a.  nothing  herein  will be  construed  to  release  either  party  of any
     obligation matured prior to the effective date of the termination;

     b.  after the  effective  date of the  termination,  Licensee  may sell all
     Licensed  Products  and  parts  therefor  it has on  hand  at the  date  of
     termination; and

     c.   Licensee   will  be   bound   by  the   provisions   of   Articles   8
     (Indemnification),  9  (Use  of  Licensor  and  Component's  Name),  and 10
     (Confidential Information) of this Agreement.

7. ASSIGNMENT

Except in connection with the sale of substantially  all of Licensee's assets to
a third party,  this Agreement may not be assigned by Licensee without the prior
written consent of Licensor, which will not be unreasonably withheld.

8. INDEMNIFICATION

Licensee agrees to hold harmless and indemnify Licensor, its officers, employees
and agents from and against any claims, demands, or causes of action whatsoever,
including without  limitation those arising on account of any injury or death of
persons or damage to property  caused by, or arising out of, or resulting  from,
the  exercise or practice of the license  granted  hereunder  by  Licensee,  its
Affiliates or their officers, employees, agents or representatives.

9. USE OF LICENSOR AND COMPONENT'S NAME

Licensee may not use the name of Licensor without express written consent.
<PAGE>
10. CONFIDENTIAL INFORMATION AND PUBLICATION

10.1 Licensor,  Data and Licensee each agree that all  information  contained in
documents  marked  "confidential"  and  forwarded  to one by  the  other  (i) be
received  in  strict  confidence,  (ii) be used  only for the  purposes  of this
Agreement,  and (iii) not be disclosed  by the  recipient  party,  its agents or
employees  without the prior written  consent of the other party,  except to the
extent that the recipient party can establish  competent written proof that such
information:

     a. was in the public domain at the time of disclosure;

     b. later became part of the public domain through no act or omission of the
     recipient party, it's employees, agents, successors or assigns;

     c. was lawfully  disclosed to the  recipient  party by a third party having
     the right to disclose it;

     d. was already known by the recipient party at the time of disclosure;

     e. was independently developed by the recipient; or

     f. is required by law or regulation to be disclosed.

10.2 Each party's obligation of confidence hereunder shall be fulfilled by using
at least the same degree of care with the other party's confidential information
as it uses to protect its own  confidential  information.  This obligation shall
exist while this Agreement is in force and for a period of 3 years thereafter.

11. ALTERNATE DISPUTE RESOLUTION

Any dispute or  controversy  arising out of or relating to this  Agreement,  its
construction  or its actual or alleged  breach will be decided by mediation.  If
the mediation does not result in a resolution of such dispute or controversy, it
will  be  finally  decided  by  an  appropriate   method  of  alternate  dispute
resolution, including without limitation,  arbitration, conducted in the city of
Las  Vegas,   Nevada  in  accordance  with  the  Commercial  Dispute  Resolution
Procedures of the American Arbitration  Association.  The arbitration panel will
include members knowledgeable in the evaluation of medical computer hardware and
software  technology.  Judgment  upon the award  rendered  may be entered in the
highest court or forum having jurisdiction,  state or federal. The provisions of
this  Article 11 will not apply to any  dispute or  controversy  as to which any
treaty or law prohibits such  arbitration.  The decision of the arbitration must
be  sanctioned  by a court of law having  jurisdiction  to be  binding  upon and
enforceable by the parties.
<PAGE>
12. GENERAL

12.1 This  Agreement  constitutes  the entire  and only  agreement  between  the
parties  for  Licensed   Subject  Matter  and  all  other  prior   negotiations,
representations,  agreements,  and  understandings  are  superseded  hereby.  No
agreements  altering or  supplementing  the terms hereof may be made except by a
written document signed by both parties.

12.2 Any notice  required  by this  Agreement  must be given by  prepaid,  first
class, certified mail, return receipt requested, addressed in the case of

Licensor and Data to:

The addresses above

or in the case of Licensee to:

The address above

or other  addresses  as may be given  from time to time  under the terms of this
notice provision.

12.3 Licensee must comply with all applicable federal,  state and local laws and
regulations in connection with its activities pursuant to this Agreement.

12.4 This Agreement  will be construed and enforced in accordance  with the laws
of the United States of America and of the State of Nevada.

12.5 Failure of Licensor to enforce a right under this Agreement will not act as
a waiver of that right or the ability to later assert that right relative to the
particular situation involved.

12.6 Headings are included herein for convenience  only and shall not be used to
construe this Agreement.

12.7 If any part of this Agreement is for any reason found to be  unenforceable,
all other parts nevertheless remain enforceable.

IN  WITNESS   WHEREOF,   parties  hereto  have  caused  their  duly   authorized
representatives to execute this Agreement.

TerraStar Marketing, Inc.                   TerraStar Data, Inc.


By                                          By
   -------------------------------             ---------------------------------
   Gary Campbell, CEO                          Gary Campbell, CEO

Eclipse Entertainment Group, Inc.

By
   -------------------------------
   Art Birzneck, President